Mark I. McCarthy
Observed names: M I McCarthy, M McCarthy, M. I McCarthy, M. I. McCARTHY, M. I. McCarthy, M. McCarthy, M.I. McCarthy, M.I. Mccarthy, MARK I MCCARTHY, MARK I. MCCARTHY, MARK MCCARTHY, MCCARTHY, M, MI McCarthy, Mark I McCarthy, Mark I. Mccarthy, Mark McCarthy, Mark I. McCarthy, McCarthy, M, McCarthy, M., McCarthy, M. I., McCarthy, M.I., McCarthy, MI, McCarthy, Mark, McCarthy, Mark I, McCarthy, Mark I., Mccarthy, Mark
Observed institutions: Broad Institute, Boston University, University of North Carolina at Chapel Hill, University of Geneva, Uppsala University, University of Copenhagen, Tokyo Medical and Dental University, Cedars-Sinai Medical Center, Boston Children's Hospital, University College Hospital, Roche (United States), Centre National de la Recherche Scientifique, Biogen (United States), European Bioinformatics Institute, St Thomas' Hospital, deCODE Genetics (Iceland), Norwegian Institute of Public Health, University Medical Center Groningen, Centre for Human Genetics, University of Helsinki, Harvard University, Royal College of Surgeons in Ireland, Imperial College Healthcare NHS Trust, University of Leicester, University of Malawi, University of Iceland, National University of Singapore, Queen Mary University of London, University of Groningen, University of Eastern Finland, Genentech, King's College London, Lund University, GlaxoSmithKline (United Kingdom), University of Aberdeen, University of Washington, QIMR Berghofer Medical Research Institute, Barts Health NHS Trust, University of Exeter, University of Cambridge, University of Michigan, Oulu University Hospital, Science for Life Laboratory, Leicester Royal Infirmary, University Hospital of Wales, Churchill Hospital, Royal London Hospital, Hammersmith Hospital, Beaumont Hospital, Erasmus MC, Northwick Park Hospital, University Hospitals of Leicester NHS Trust, TUM Klinikum, John Radcliffe Hospital, Karolinska Institutet, University of Manchester, Helmholtz Munich, National Institute for Health and Care Research, University of Bristol, University of Warwick, University of Oxford, Massachusetts General Hospital, NIHR Oxford Biomedical Research Centre, London School of Hygiene & Tropical Medicine, Bristol-Myers Squibb (United States), Manchester University NHS Foundation Trust, Kuopio University Hospital, National Heart, Lung, and Blood Institute, St Mary's Hospital, Lancet Laboratories, JS Link (South Korea), GlaxoSmithKline (United States), Wellcome/MRC Institute of Metabolic Science, Arthritis UK, NIHR Bristol Biomedical Research Centre, Framingham Heart Study, Amsterdam Public Health, Oxford Centre for Diabetes, Endocrinology and Metabolism, IRCCS Ospedale San Raffaele, Institute for Molecular Medicine Finland, Jena University Hospital, HudsonAlpha Institute for Biotechnology, Oxford University Hospitals NHS Trust, William Harvey Research Institute, Addenbrooke's Hospital, Whitehead Institute for Biomedical Research, MRC Epidemiology Unit, NIHR Manchester Biomedical Research Centre, German Center for Diabetes Research, German Institute of Human Nutrition, MRC Integrative Epidemiology Unit, NIHR Cambridge Biomedical Research Centre, Institut für Humangenetik, Wake Forest University Health Sciences, Center for Sepsis Control and Care, Pohjois-Savon sairaanhoitopiiri, F. Widjaja Inflammatory Bowel Disease Institute, University of Bergen, University College London, Wake Forest University, Imperial College London, Geisinger Health System, University of Tartu, Brunel University of London, Technical University of Munich, All India Institute of Medical Sciences, University of Brighton, Vrije Universiteit Amsterdam, Wellcome Trust, Vanderbilt University Medical Center, Medical Research Council, The University of Texas Health Science Center at Houston, University of KwaZulu-Natal, Stanford University, McMaster University, University of Oulu, KU Leuven
ORCID: 0000-0002-4393-0510
Observed ORCID: 0000-0002-4393-0510
OpenAlex ID: A5064948585
